Efficacy and Safety of Lisdexamfetamine Versus Topiramate Versus Naltrexone/Bupropion in Individuals With Binge Eating Disorder: A Network Meta‐Analysis

Documenti analoghi

• Comparative Analysis of Glucagon Receptor Agonists vs. Resmetirom in MASLD and MASH: Network Meta‐Analysis of Clinical Trials
  di: Celina R. Andonie, et al.
  Pubblicazione: (2025)
• Psychotherapy‐Supported Lisdexamfetamine Tapering in Binge‐Eating Disorder: Spotlighting a Critical Research Gap
  di: Cristin D. Runfola, et al.
  Pubblicazione: (2026)
• Cognitive‐Behavioral Therapy and Lisdexamfetamine, Alone and Combined, for Binge‐Eating Disorder: Secondary Outcomes of a Randomized Controlled Trial
  di: Carlos M. Grilo, et al.
  Pubblicazione: (2025)
• Examining Heterogeneity of Patient Outcomes in a Randomized Controlled Trial for Binge‐Eating Disorder Testing Cognitive‐Behavioral Therapy and Lisdexamfetamine, Alone and Combined
  di: Sydney Yurkow, et al.
  Pubblicazione: (2026)
• Exploring Drivers of Binge Eating in Individuals With Food Insecurity and Recurrent Binge Eating: A Qualitative Analysis
  di: Emilie A. Green, et al.
  Pubblicazione: (2025)